CRISPR Cas genome editing illustration with DNA, guide RNA, and editing complex

Human Cell-Line Research Models

Genome Editing (CRISPR/Cas)

CRISPR/Cas genome editing enables precise DNA modification in human cell-line models, including gene knockout, gene knock-in, gene correction, and targeted sequence changes.

We provide customized editing-strategy design, guide RNA development, clone isolation, and molecular validation to support functional genomics, disease modeling, drug-target validation, and preclinical research.

Customized genome editing services are offered for human cell-line research models.

Customized Editing Services

Genome Editing Capabilities

Each project is planned around the desired genomic change, the selected human cell-line model, and the required validation strategy.

Editing Strategy and Guide RNA Design

Project-specific editing plans and guide RNA development aligned with the target locus and intended modification.

Gene Knockout and Gene Knock-In

Targeted disruption or sequence insertion in human cell-line models to support mechanistic and functional studies.

Gene Correction and Targeted Changes

Defined sequence correction and targeted DNA modifications based on the project objective.

Single-Clone Isolation and Screening

Isolation and screening of candidate clones to identify cell populations carrying the intended edit.

Molecular Confirmation

Molecular testing to confirm the intended edit and support selection of edited cell-line clones.

Research Applications

Support for Cell-Line Model Development

Genome editing can create defined research models for studies that require controlled genetic changes.

Functional Genomics

Investigate gene function, pathway relationships, and phenotype-associated mechanisms in controlled cell-line models.

Disease Modeling

Create defined cellular models for studying disease-associated variants and molecular mechanisms.

Drug-Target Validation

Evaluate target relevance and support mechanism-of-action studies using engineered cell lines.

Preclinical Research

Develop edited cell-line models for exploratory and preclinical research workflows.

From Editing Design to Molecular Confirmation

The project workflow is customized to the cell line, target locus, editing objective, and screening requirements.

Design the Editing Strategy

Define the target, intended sequence change, guide RNA approach, and molecular confirmation plan.

Edit the Cell-Line Model

Introduce the CRISPR/Cas editing system into the selected human cell-line model.

Isolate and Screen Clones

Generate single-cell-derived candidates and screen for the intended genomic modification.

Confirm the Edited Cell Line

Perform molecular confirmation and provide project-specific results for selected clones.

Start Your Genome Editing Project

Submit your cell-line model, target gene, intended modification, and validation requirements through the service order form.

Research Use Only. Genome editing services are intended for human cell-line research models and are not for use in diagnostic procedures or direct clinical applications.